RMDNeutral (ASignal Rank 3/4)

ASignal's 10+ AI agent pipeline rates RMD as Neutral with 74% confidence in the Healthcare sector.

AI Analysis Summary

RMD presents significant downside risk due to extreme leverage, bearish technicals, and a strong negative price forecast. the signal indicates unfavorable entry conditions.

Investment Framework Assessment

Evaluated through three legendary investor frameworks:

  • Warren Buffett (Value Investing): Grade D — 35/100
  • Bill Ackman (Activist Investing): Grade B — 60/100
  • Ray Dalio (Macro/Risk Parity): Grade D — 35/100

Consensus: Bearish

Price Intelligence

  • Current price: $219.85
  • Price target: $187.30 (-14.8%)
  • Risk level: high
  • Horizon: medium term

Quality Assessment

  • Balance sheet: concerning
  • Cash flow: fair
  • Competitive moat: none

Peer Group Analysis

RMD is in the “Oversold & Compressed” cluster alongside ZBH, XOM, WFC, WDAY, VLO (128 stocks total). 0 of 128 peers are currently bullish.

RMD Neutral Signal — AI Analysis | ASignal